SIX MONTHS CSII TREATMENT IMPROVES ARTERIAL STIFFNESS AND ENDOTHELIAL GLYCOCALYX VS MDI INTENSIFICATION IN PATIENTS WITH TYPE 1 DIABETES INDEPENDENTLY OF GLYCEMIC CONTROL.

被引：0
作者：
Kountouri, A. [1 ]
Thymis, J. [2 ]
Kousathana, F. [1 ]
Balampanis, K. [1 ]
Pliouta, L. [1 ]
Prentza, V. [1 ]
Katogiannis, K. [2 ]
Kostelli, G. [2 ]
Barmpagianni, A. [3 ]
Liatis, S. [3 ]
Ikonomidis, I. [2 ]
Lambadiari, V. [1 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Dept Internal Med 2, Sch Med, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Dept Cardiol 2, Sch Med, Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Laiko Gen Hosp, Dept Propaedeut & Internal Med 1, Sch Med, Athens, Greece
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P201 / #3
引用
收藏
页码：A153 / A153
页数：1
相关论文
共 36 条
  • [31] Long-Term Glycemic Control in Patients with Long-Standing (>20 Years) Type 1 Diabetes Mellitus: Combined Islet Transplantation vs Intensive Insulin Treatment
    Locher, Rebecca
    Gerber, Philipp A.
    Zuellig, Richard A.
    Pfammatter, Thomas
    Wuethrich, Rudolf
    Spinas, Giatgen A.
    Lehmann, Roger
    DIABETES, 2010, 59 : A38 - A38
  • [32] Type 2 Diabetes Patients with Poor Glycemic Control Using Multiple Daily Insulin Injections (MDI): Lower A1C and Total Daily Insulin Dose (TDD) when Switching to V-Go vs. Standard of Care (SoC)
    Strange, Poul
    Shi, Leon
    Abbott, Scott
    Nguyen, Matthew
    Cziraky, Mark
    Wasser, Thomas
    Larholt, Kay
    DIABETES, 2017, 66 : A278 - A278
  • [33] Effects of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Endothelial Glycocalyx, Arterial Function, and Myocardial Work Index in Patients With Type 2 Diabetes Mellitus After 12-Month Treatment
    Ikonomidis, Ignatios
    Pavlidis, George
    Thymis, John
    Birba, Dionysia
    Kalogeris, Aimilianos
    Kousathana, Foteini
    Kountouri, Aikaterini
    Balampanis, Konstantinos
    Parissis, John
    Andreadou, Ioanna
    Katogiannis, Konstantinos
    Dimitriadis, George
    Bamias, Aristotelis
    Iliodromitis, Efstathios
    Lambadiari, Vaia
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (09):
  • [34] TREATMENT OPTIMIZATION WITH SODIUM/GLUCOSE COTRANSPORTER-2 INHIBITORS, DIPEPTIDYL PEPTIDASE-4 INHIBITORS OR GLYCAGONE LIKE PEPTIDE-1 IMPROVES VASCULAR DYSFUNCTION AND ACHIEVES BETTER GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Siasos, Gerasimos
    Bletsa, Evanthia
    Stampouloglou, Panagiota
    Mourouzis, Konstantinos
    Tsigkou, Vasiliki
    Gouliopoulos, Nikolaos
    Antonopoulos, Alexis
    Oikonomou, Evangelos
    Thanopoulou, Anastasia
    Vryonidou, Andromahi
    Paschou, Stavroula A.
    Politou, Marianna
    Tentolouris, Nikolaos
    Tousoulis, Dimitris
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 190 - 190
  • [35] Patients with longstanding type 1 diabetes show improved self awareness of hypoglycaemia measured during clamped hypoglycaemic challenges after a six month intensive treatment period in the HypoCOMPASS Study: comparison of optimised multiple daily injections (MDI) and continuous insulin infusion therapy (CSII) with or without adjunctive real-time continuous glucose monitoring (RTCGM)
    Leelarathna, L.
    Little, S. A.
    Walkinshaw, E.
    Tan, H. K.
    Kumareswaran, K.
    Solomon, A. Lubina
    Flanagan, D.
    Heller, S.
    Shaw, J. A. M.
    Evans, M. L.
    Chow, E.
    DIABETIC MEDICINE, 2013, 30 : 14 - 14
  • [36] Treatment With the Human Once-Weekly Glucagon-Like Peptide-1 Analog Taspoglutide in Combination With Metformin Improves Glycemic Control and Lowers Body Weight in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone A double-blind placebo-controlled study
    Nauck, Michael A.
    Ratner, Robert E.
    Kapitza, Christoph
    Berria, Rachele
    Boldrin, Mark
    Balena, Raffaella
    DIABETES CARE, 2009, 32 (07) : 1237 - 1243
1234